| pubmed-article:7666958 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0007776 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0022655 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0001613 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C1522565 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0338656 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0487742 | lld:lifeskim |
| pubmed-article:7666958 | lifeskim:mentions | umls-concept:C0596620 | lld:lifeskim |
| pubmed-article:7666958 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7666958 | pubmed:dateCreated | 1995-10-12 | lld:pubmed |
| pubmed-article:7666958 | pubmed:abstractText | We compared the correlation of PET and MRI with neuropsychological tests in 26 patients with probable Alzheimer's disease (AD). The width of the temporal horns and the third ventricle, regional metabolic rates of glucose (rCMRGlu) and the proportion of cerebrospinal fluid space in mesial temporal and temporoparietal cortical regions were measured with three-dimensionally coregistered PET and MRI in two planes perpendicular to the Sylvian fissure. Highly significant correlations between rCMRGlu and neuropsychological tests were found mainly in the temporoparietal cortex, with and without correction for atrophy. Correlations of similar magnitude were seen also between most tests and the width of the temporal horns and third ventricle. Changes in the third ventricle and mesial temporal lobe were best seen with MRI, whereas PET most clearly depicted alterations in neocortical association areas. These two aspects of the disease correlated with the severity of dementia to a similar degree. | lld:pubmed |
| pubmed-article:7666958 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7666958 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7666958 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7666958 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7666958 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7666958 | pubmed:month | May | lld:pubmed |
| pubmed-article:7666958 | pubmed:issn | 0028-3940 | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:HeissW DWD | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:KesslerJJ | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:HerholzKK | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:PietrzykUU | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:GrondMM | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:MielkeRR | lld:pubmed |
| pubmed-article:7666958 | pubmed:author | pubmed-author:SlanskyII | lld:pubmed |
| pubmed-article:7666958 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7666958 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:7666958 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7666958 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7666958 | pubmed:pagination | 270-7 | lld:pubmed |
| pubmed-article:7666958 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:meshHeading | pubmed-meshheading:7666958-... | lld:pubmed |
| pubmed-article:7666958 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7666958 | pubmed:articleTitle | Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism. | lld:pubmed |
| pubmed-article:7666958 | pubmed:affiliation | Max-Planck-Institut für neurologische Forschung, Köln, Germany. | lld:pubmed |
| pubmed-article:7666958 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7666958 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7666958 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7666958 | lld:pubmed |
